MYC and neoplasm: Recently, the tumor suppressor function of BCOR has been confirmed in vivo in a Myc-driven lymphomagenesis model as well as in transgenic mice expressing a truncated form of BCOR (partial internal deletion) that cannot bind to BCL6 [30, 31].